Your browser doesn't support javascript.
loading
Three-dimensional nuclear architecture distinguishes thyroid cancer histotypes.
Rangel-Pozzo, Aline; Dos Santos, Filipe F; Dettori, Tinuccia; Giulietti, Matteo; Frau, Daniela Virginia; Galante, Pedro A F; Vanni, Roberta; Pathak, Alok; Fischer, Gabor; Gartner, John; Caria, Paola; Mai, Sabine.
Afiliación
  • Rangel-Pozzo A; CancerCare Manitoba Research Institute, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada.
  • Dos Santos FF; Centro de Oncologia Molecular, Hospital Sirio-Libanes, Sao Paulo, Brazil.
  • Dettori T; Department of Biochemistry, Chemistry Institute, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Giulietti M; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
  • Frau DV; Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy.
  • Galante PAF; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
  • Vanni R; Centro de Oncologia Molecular, Hospital Sirio-Libanes, Sao Paulo, Brazil.
  • Pathak A; University of Cagliari, Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
  • Fischer G; Department of Surgery, University of Manitoba, Winnipeg, Canada.
  • Gartner J; Department of Pathology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
  • Caria P; Department of Pathology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
  • Mai S; Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy.
Int J Cancer ; 153(10): 1842-1853, 2023 11 15.
Article en En | MEDLINE | ID: mdl-37539710
ABSTRACT
Molecular markers can serve as diagnostic tools to support pathological analysis in thyroid neoplasms. However, because the same markers can be observed in some benign thyroid lesions, additional approaches are necessary to differentiate thyroid tumor subtypes, prevent overtreatment and tailor specific clinical management. This applies particularly to the recently described variant of thyroid cancer referred to as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). This variant has an estimated prevalence of 4.4% to 9.1% of all papillary thyroid carcinomas worldwide. We studied 60 thyroid lesions 20 classical papillary thyroid carcinoma (CPTC), 20 follicular variant of PTC (FVPTC) and 20 NIFTP. We examined morphological and molecular features to identify parameters that can differentiate NIFTP from the other PTC subtypes. When blindly investigating the nuclear architecture of thyroid neoplasms, we observed that NIFTP has significantly longer telomeres than CPTC and FVPTC. Super-resolved 3D-structured illumination microscopy demonstrated that NIFTP is heterogeneous and that its nuclei contain more densely packed DNA and smaller interchromatin spaces than CPTC and FVPTC, a pattern that resembles normal thyroid tissue. These data are consistent with the observed indolent biological behavior and favorable prognosis associated with NIFTP, which lacks BRAFV600E mutations. Of note, next-generation thyroid oncopanel sequencing was unable to distinguish the thyroid cancer histotypes in our study cohort. In summary, our data suggest that 3D nuclear architecture can be a powerful analytical tool to diagnose and guide clinical management of NIFTP.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma Folicular Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma Folicular Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Canadá